IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...

Despite working on Terraria 1.4.5 for years, developer Re-Logic has naturally already found itself with even more ideas to cram into its ever-expanding sandbox game. The team that simply can't be ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company, which sources its ...

Leon is a young, aspiring gaming journalist from the city of Lincolnshire, England. Since the early years of his life, he has been obsessed with gaming, stemming from his initial introduction through ...

Security data pipeline platform startup Realm.Security Inc. today announced that it has raised $15 million in new funding to accelerate product development and market expansion. Founded in 2024 by ...

New technologies are enabling scientists to tackle previously elusive physics problems. The macroscopic realm, which consists of everything from falling balls to orbiting planets, can be explained by ...

As exciting as the looming Terraria 1.4.5 update is, my attention has just been stolen away by modder 'ScottieKnowz' and their imminent open beta launch for Path of Terraria. This hugely impressive ...

Researchers have identified handling of freshwater fish as the key risk factor in an outbreak in Hong Kong. Invasive Group B Streptococcus (GBS) infection caused by Sequence Type 283 (ST283) has also ...

Combining open-world exploration and challenging combat, the Tarnished can rise and take on Elden Ring the Board Game: Realm of the Grafted King. But does it capture the feel of the lauded video game?

It’s time to shed some light on what the Lumenith Realm-lords will be doing in Ghyran with these rule updates. The Lumineth Realm-lords are heading to the Realm of Life and they’ve got some new toys ...

Despite treatment options, GBS stays severe, with a mortality rate of 3%-10%. The mechanisms behind GBS are poorly understood and new therapeutic options are needed.

A post-marketing review by the FDA detected an increased risk of the autoimmune condition in patients inoculated with GSK’s Arexvy and Pfizer’s Abrysvo, prompting the regulator to require adjustments ...